Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 06, 2022

SELL
$1.56 - $2.93 $131 - $246
-84 Closed
0 $0
Q2 2021

Jul 22, 2021

SELL
$4.17 - $5.74 $1,684 - $2,318
-404 Reduced 82.79%
84 $0
Q1 2021

Apr 27, 2021

SELL
$5.28 - $9.64 $971 - $1,773
-184 Reduced 27.38%
488 $3,000
Q4 2020

Feb 08, 2021

SELL
$5.75 - $7.13 $511 - $634
-89 Reduced 11.7%
672 $4,000
Q3 2020

Nov 02, 2020

SELL
$4.9 - $7.12 $622 - $904
-127 Reduced 14.3%
761 $4,000
Q2 2020

Jul 16, 2020

SELL
$6.43 - $9.86 $1,286 - $1,972
-200 Reduced 18.38%
888 $6,000
Q1 2020

Apr 17, 2020

BUY
$6.36 - $10.05 $324 - $512
51 Added 4.92%
1,088 $7,000
Q4 2019

Jan 28, 2020

SELL
$8.49 - $12.81 $390 - $589
-46 Reduced 4.25%
1,037 $9,000
Q3 2019

Oct 18, 2019

SELL
$5.58 - $14.47 $61 - $159
-11 Reduced 1.01%
1,083 $12,000
Q2 2019

Jul 16, 2019

SELL
$5.22 - $9.08 $4,943 - $8,598
-947 Reduced 46.4%
1,094 $6,000
Q1 2019

Apr 23, 2019

BUY
$5.35 - $9.82 $10,833 - $19,885
2,025 Added 12656.25%
2,041 $16,000
Q1 2019

Apr 23, 2019

SELL
$5.35 - $9.82 $11,106 - $20,386
-2,076 Reduced 99.24%
16 $16,000
Q4 2018

Jan 29, 2019

BUY
$3.43 - $6.19 $6,287 - $11,346
1,833 Added 707.72%
2,092 $10,000
Q3 2018

Oct 15, 2018

SELL
$4.75 - $14.5 $5,410 - $16,515
-1,139 Reduced 81.47%
259 $1,000
Q2 2018

Jul 06, 2018

SELL
$13.3 - $17.45 $6,144 - $8,061
-462 Reduced 24.84%
1,398 $19,000
Q1 2018

Apr 19, 2018

SELL
$14.7 - $24.95 $970 - $1,646
-66 Reduced 3.43%
1,860 $29,000
Q4 2017

Apr 19, 2018

SELL
$19.9 - $29.25 $696 - $1,023
-35 Reduced 1.78%
1,926 $44,000
Q3 2017

Apr 23, 2018

BUY
$15.1 - $19.25 $15,100 - $19,250
1,000 Added 104.06%
1,961 $36,000
Q2 2017

Apr 23, 2018

BUY
N/A
491 Added 104.47%
961 $19,000
Q1 2017

Apr 23, 2018

BUY
N/A
470
470 $10,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.